Aggregation of cancer in first-degree relatives of patients with glioma

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 11, 2007, Pages 2491-2495

  Scheurer, Michael E ^a   Etzel, Carol J ^a   Liu, Mei ^a   El Zein, Randa ^a   Airewele, Gladstone E ^b   Malmer, Beatrice ^c   Aldape, Kenneth D ^a   Weinberg, Jeffrey S ^a   Yung, W K Alfred ^a   Bondy, Melissa L ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER GENETICS; CANCER INCIDENCE; CHILD; COMPARATIVE STUDY; CONFIDENCE INTERVAL; FAMILY HISTORY; FEMALE; GENETIC LINKAGE; GLIOMA; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PANCREAS CANCER; PRIORITY JOURNAL; RELATIVE; SARCOMA; TIME SERIES ANALYSIS;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; FAMILY HEALTH; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HUMANS; INFANT; MIDDLE AGED; SEER PROGRAM; TEXAS;

EID: 38849205382     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0576     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
2. Bondy M, Wiencke J, Wrensch M, Kyritsis AP. Genetics of primary brain tumors: a review. J Neurooncol 1994;18:69-81.
3. Li Y, Millikan RC, Carozza S, et al. p53 mutations in malignant gliomas. Cancer Epidemiol Biomarkers Prev 1998;7:303-8.
4. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-8.
5. Hemminki K, Li X, Collins VP. Parental cancer as a risk factor for brain tumors (Sweden). Cancer Causes Control 2001;12:195-9.
6. Hill DA, Inskip PD, Shapiro WR, et al. Cancer in first-degree relatives and risk of glioma in adults. Cancer Epidemiol Biomarkers Prev 2003;12:1443-8.
7. Malmer B, Gronberg H, Bergenheim AT, Lenner P, Henriksson R. Familial aggregation of astrocytoma in northern Sweden: an epidemiological cohort study. Int J Cancer 1999;81:366-70.
8. Malmer B, Henriksson R, Gronberg H. Familial brain tumours - genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer 2003;106:260-3.
9. O'Neill BP, Blondal H, Yang P, et al. Risk of cancer among relatives of patients with glioma. Cancer Epidemiol Biomarkers Prev 2002;11:921-4.
10. Wrensch M, Lee M, Miike R, et al. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol 1997;145:581-93.
11. WHO: ICD-O-3 international classification of diseases for oncology. Geneva: WHO; 2000.
12. Lustabader ED, McLaughlin PR. CAGE: cohort analysis for genetic epidemiology. Philadelphia (PA): Fox Chase Cancer Center; 1995.
13. Airewele G, Adatto P, Cunningham J, et al. Family history of cancer in patients with glioma: a validation study of accuracy. J Natl Cancer Inst 1998;90:543-4.
14. Malmer B, Henriksson R, Gronberg H. Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma. Neuroepidemiology 2002;21:279-86.
15. Paunu N, Pukkala E, Laippala P, et al. Cancer incidence in families with multiple glioma patients. Int J Cancer 2002;97:819-22.
16. Cannon-Albright LA, Goldgar DE, Meyer LJ, et al. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-22. Science 1992;258:1148-52.
17. Cannon-Albright LA, Kamb A, Skolnick M. A review of inherited predisposition to melanoma. Semin Oncol 1996;23:667-72.
18. Bello MJ, de Campos JM, Vaquero J, et al. Molecular and cytogenetic analysis of chromosome 9 deletions in 75 malignant gliomas. Genes Chromosomes Cancer 1994;9:33-41.
19. James CD, He J, Carlbom E, et al. Chromosome 9 deletion mapping reveals interferon a and interferon β-1 gene deletions in human glial tumors. Cancer Res 1991;51:1684-8.
20. Randerson-Moor JA, Harland M, Williams S, et al. A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Mol Genet 2001;10:55-62.